Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C
- 24 April 2007
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 79 (6) , 701-713
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Diagnostic Algorithm for Chronic Hepatitis C Virus Infection: Role of the New HCV-Core Antigen AssayZeitschrift für Gastroenterologie, 2005
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Host factors and failure of interferon-α treatment in hepatitis C virusHepatology, 2004
- Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial *Journal of Viral Hepatitis, 2003
- Virus‐specific antibody titres in different phases of hepatitis C virus infectionJournal of Viral Hepatitis, 2002
- Antigenic Heterogeneity of the Hepatitis C Virus NS5A ProteinJournal of Clinical Microbiology, 2002
- Significance of the Anti‐E2 Response in Self‐Limited and Chronic Hepatitis C Virus Infections in Chimpanzees and in HumansThe Journal of Infectious Diseases, 1999
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Rapid “tea-bag” peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteinsImmunology Letters, 1991